Stay updated on Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma

Sign up to get notified when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page changed from a 403 Forbidden message to a “TypeError: Failed to fetch” message, and the NIH transition notice was removed.
    Difference
    1%
    Check dated 2026-11-07T11:55:44.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:54:11.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:15:14.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision marker changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:10:05.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T14:10:45.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the study details with a basic error screen and navigation.
    Difference
    21%
    Check dated 2026-09-19T18:07:58.000Z thumbnail image

Stay in the know with updates to Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.